Cell, 2026 Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome Koprulu M., Smith-Byrne K., Ferolito B. et al. Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2026 Evidence for an energy conservation model of inflammaging and immunosenescence in the US Health and Retirement Study and UK Biobank Aronoff J., Franck M., Cohen A. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Cell Reports, 2026 Cohesin complex cooperates with PU.1 at super-enhancers to regulate the differentiation and identity of conventional dendritic cells Choubey P., Kumar A., Podder S. et al. Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Serum | | | | |
American Journal of Preventive Cardiology, 2026 Large-scale plasma proteomics improves prediction of heart failure among MASLD individuals: A prospective cohort study Xiong Z., Chen S., Huang H. et al. Olink Explore 3072/384Metabolic DiseasesCVDHepatologyPatient StratificationPlasma | | | | |
Journal of Extracellular Biology, 2026 The Proteo‐Transcriptome of Extracellular Vesicles and Particles Is Largely Preserved After Cryopreservation Nose Y., Valle D., Gonsalves T. et al. Olink Target 96OncologyTechnical StudiesTechnical EvaluationEV Lysate | | | | |
eBioMedicine, 2026 Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIV Wang Z., Wang Y., Peters B. et al. Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma | | | | |
Translational Oncology, 2026 Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis Huang J., Gao L., Glazutdinova L. et al. Olink Explore 3072/384OncologyPatient StratificationSerum | | | | |
Journal of Clinical & Translational Endocrinology, 2026 Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing’s syndrome van Houten P., van de Ven A., van Herwaarden A. et al. Olink Target 96EndocrinologyPathophysiologyPlasma | | | | |
npj Digital Medicine, 2026 Leveraging population-scale proteomic data with deep learning for head and neck cancer detection in saliva Shakeel A., Merriel S., Smith J. et al. Olink Target 96Olink Explore 3072/384OncologyWider Bioinformatics StudiesTechnical EvaluationData SciencePlasmaSaliva | | | | |
ERJ Open Research, 2026 Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease Chen J., Shrine N., Coley K. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma | | | | |
Blood Cancer Journal, 2026 A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients Firestone R., Simhal A., Akhlaghi T. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Atherosclerosis, 2026 Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study Wadström B., Wulff A., Pedersen K. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
JHEP Reports, 2026 Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B Holmberg M., Niehrs A., Dalgard O. et al. Olink Target 96HepatologyPathophysiologySerum | | | | |
eBioMedicine, 2026 A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector–based vaccines Hertoghs N., Serroyen J., Tolboom J. et al. Olink Explore 3072/384Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Archives of Medical Science, 2026 Deciphering the Interplay Between Inflammatory Factors and Brain Structural Features in Epilepsy Fang S., Dong X., Li X. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Neurobiology of Disease, 2026 Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity Jin H., Meng L., Yulug B. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Neurobiology of Disease, 2026 A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke Tan H., Gong H., Li H. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Lung Cancer, 2026 A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort Liang J., Feng Y., Gui D. et al. Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma | | | | |
Journal of Infection, 2026 Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir Suanzes P., Grau-Expósito J., Navarro J. et al. Olink Target 48Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Biotechnology, 2026 mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression Marks A., Siu S., Bianchini F. et al. Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Cell Culture Supernatant | | | | |